| pubmed-article:9609216 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9609216 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:9609216 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9609216 | lifeskim:mentions | umls-concept:C0443315 | lld:lifeskim |
| pubmed-article:9609216 | lifeskim:mentions | umls-concept:C0149871 | lld:lifeskim |
| pubmed-article:9609216 | lifeskim:mentions | umls-concept:C0019139 | lld:lifeskim |
| pubmed-article:9609216 | lifeskim:mentions | umls-concept:C0585361 | lld:lifeskim |
| pubmed-article:9609216 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:9609216 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:9609216 | lifeskim:mentions | umls-concept:C0332173 | lld:lifeskim |
| pubmed-article:9609216 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:9609216 | pubmed:dateCreated | 1998-7-22 | lld:pubmed |
| pubmed-article:9609216 | pubmed:abstractText | Clinical trials have been performed to compare with standard heparin a once or a twice daily regimen of low-molecular-weight heparin but no direct comparison has been done between these two low-molecular-weight heparin regimens in terms of efficacy and safety with a long-term clinical evaluation. | lld:pubmed |
| pubmed-article:9609216 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9609216 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9609216 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9609216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9609216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9609216 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9609216 | pubmed:month | May | lld:pubmed |
| pubmed-article:9609216 | pubmed:issn | 0340-6245 | lld:pubmed |
| pubmed-article:9609216 | pubmed:author | pubmed-author:FiessingerJ... | lld:pubmed |
| pubmed-article:9609216 | pubmed:author | pubmed-author:WenzelEE | lld:pubmed |
| pubmed-article:9609216 | pubmed:author | pubmed-author:d'AzemarPP | lld:pubmed |
| pubmed-article:9609216 | pubmed:author | pubmed-author:BangaJ DJD | lld:pubmed |
| pubmed-article:9609216 | pubmed:author | pubmed-author:SagnardLL | lld:pubmed |
| pubmed-article:9609216 | pubmed:author | pubmed-author:CharbonnierB... | lld:pubmed |
| pubmed-article:9609216 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9609216 | pubmed:volume | 79 | lld:pubmed |
| pubmed-article:9609216 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9609216 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9609216 | pubmed:pagination | 897-901 | lld:pubmed |
| pubmed-article:9609216 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9609216 | pubmed:meshHeading | pubmed-meshheading:9609216-... | lld:pubmed |
| pubmed-article:9609216 | pubmed:meshHeading | pubmed-meshheading:9609216-... | lld:pubmed |
| pubmed-article:9609216 | pubmed:meshHeading | pubmed-meshheading:9609216-... | lld:pubmed |
| pubmed-article:9609216 | pubmed:meshHeading | pubmed-meshheading:9609216-... | lld:pubmed |
| pubmed-article:9609216 | pubmed:meshHeading | pubmed-meshheading:9609216-... | lld:pubmed |
| pubmed-article:9609216 | pubmed:meshHeading | pubmed-meshheading:9609216-... | lld:pubmed |
| pubmed-article:9609216 | pubmed:meshHeading | pubmed-meshheading:9609216-... | lld:pubmed |
| pubmed-article:9609216 | pubmed:meshHeading | pubmed-meshheading:9609216-... | lld:pubmed |
| pubmed-article:9609216 | pubmed:meshHeading | pubmed-meshheading:9609216-... | lld:pubmed |
| pubmed-article:9609216 | pubmed:meshHeading | pubmed-meshheading:9609216-... | lld:pubmed |
| pubmed-article:9609216 | pubmed:meshHeading | pubmed-meshheading:9609216-... | lld:pubmed |
| pubmed-article:9609216 | pubmed:meshHeading | pubmed-meshheading:9609216-... | lld:pubmed |
| pubmed-article:9609216 | pubmed:meshHeading | pubmed-meshheading:9609216-... | lld:pubmed |
| pubmed-article:9609216 | pubmed:meshHeading | pubmed-meshheading:9609216-... | lld:pubmed |
| pubmed-article:9609216 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9609216 | pubmed:articleTitle | Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. | lld:pubmed |
| pubmed-article:9609216 | pubmed:affiliation | University Hospital Trousseau, Tours, France. | lld:pubmed |
| pubmed-article:9609216 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9609216 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9609216 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:9609216 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9609216 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:9609216 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9609216 | lld:pubmed |
